Andrea Ricci
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Hepcidin dynamics predict outcomes in COVID-19 patients treated with interleukin inhibitors.
Journal: Internal and emergency medicine
Published: April 15, 2026
Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patients.
Journal: International journal of pharmaceutics
Published: October 21, 2025
Genome-wide association for sarcoidosis identifies novel risk loci and genetic heritability in African and European ancestries: a meta-analysis from the Finngen, Million Veteran Program, UK Biobank, and Biobank Japan datasets.
Journal: Orphanet journal of rare diseases
Published: April 28, 2025
Porphyrias: Pathophysiology and clinical management recommendations for hepatologists.
Journal: Hepatology communications
Published: March 21, 2025
Haematological parameters in erythropoietic protoporphyria: A multi-national study.
Journal: British journal of haematology
Published: March 19, 2025
Alterations in iron status predict cardiac response to blood transfusion in β-thalassemia major.
Journal: Scientific reports
Published: November 14, 2024
CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: January 26, 2023
Labile plasma iron and echocardiographic parameters are associated with cardiac events in β-thalassemic patients.
Journal: European journal of clinical investigation
Published: November 16, 2022
Iron Metabolism in the Disorders of Heme Biosynthesis.
Journal: Metabolites
Published: August 03, 2022
Givosiran for the treatment of acute hepatic porphyria.
Journal: Expert review of clinical pharmacology
Published: May 09, 2022
Endothelial Dysfunction in Acute Hepatic Porphyrias.
Journal: Diagnostics (Basel, Switzerland)
Published: March 31, 2022
Last Updated: 09/26/2026